1. Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivatives
- Author
-
Stefania Grimaudo, Riccardo Baruchello, Maria Meli, Riccardo Rondanin, Romeo Romagnoli, Manlio Tolomeo, Paolo Marchetti, Giacomo Padroni, Sara Fochi, Rosaria Maria Pipitone, Daniele Simoni, Cristiana Costantini, Rondanin,R, Simoni, D, Romagnoli, R, Baruchello,R, Marchetti,P, Costantini, C, Fochi, S, Padroni,G, Grimaudo, S, Pipitone, RM, Meli, M, and Tolomeo, M
- Subjects
Clinical Biochemistry ,Fusion Proteins, bcr-abl ,Pharmaceutical Science ,Apoptosis ,Biochemistry ,Settore MED/15 - Malattie Del Sangue ,Cell Line ,Structure-Activity Relationship ,Pimozide ,Settore BIO/13 - Biologia Applicata ,hemic and lymphatic diseases ,Drug Discovery ,medicine ,STAT5 Transcription Factor ,Cytotoxic T cell ,Humans ,Phosphorylation ,Molecular Biology ,Transcription factor ,STAT5 ,Cell Proliferation ,biology ,Dose-Response Relationship, Drug ,Molecular Structure ,Chemistry ,STAT5 inhibitors,Pimozide,BCR/ABL expressing leukemia, Apoptosis,Cell growth inhibition ,Organic Chemistry ,Cell Cycle ,medicine.disease ,Settore CHIM/08 - Chimica Farmaceutica ,Leukemia ,Cancer research ,biology.protein ,Settore BIO/14 - Farmacologia ,Molecular Medicine ,K562 Cells ,medicine.drug ,Chronic myelogenous leukemia - Abstract
STATs are transcription factors acting as intracellular signaling after stimulation with cytokines, growth factors and hormones. STAT5 is also constitutively active in many forms of cancers, including chronic myelogenous leukemia, acute lymphoblastic leukemia and Hodgkin's lymphoma. Recently, literature reported that the neuroleptic drug pimozide inhibits STAT5 phosphorylation inducing apoptosis in CML cells. We undertook an investigation from pimozide structure, obtaining simple derivatives with cytotoxic and STAT5-inhibitory activity, two of them markedly more potent than pimozide.
- Published
- 2014